Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
Zhidong Zhou, Wuan Ting Saw, Patrick Ho, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Role of dopamine in the pathophysiology of Parkinson’s disease
Zhidong Zhou, Ling Yi, Qing Wang, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 79
Pathogenesis of Parkinson’s Disease
Bin Xiao, Zhidong Zhou, Yinxia Chao, et al.
Neurologic Clinics (2025)
Closed Access | Times Cited: 2
Advances in fluorescent probe development for bioimaging of potential Parkinson's biomarkers
Xiaoqian Sun, Qingqing Jiang, Yu Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116195-116195
Closed Access | Times Cited: 12
The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A review
Samira Hassani, Abolghasem Esmaeili
Ageing Research Reviews (2024) Vol. 97, pp. 102299-102299
Closed Access | Times Cited: 11
Midbrain organoids for Parkinson's disease (PD) - A powerful tool to understand the disease pathogenesis
Harysh Winster Suresh Babu, Sindduja Muthu Kumar, Harsimrat Kaur, et al.
Life Sciences (2024) Vol. 345, pp. 122610-122610
Closed Access | Times Cited: 9
A glucan from Ganoderma lucidum: structural characterization and the anti-inflammatory effect on Parkinson's Disease via regulating dysfunctions of intestinal microecology and inhibiting TLR4/MyD88/NF-κB signaling pathway
Li Chen, Yanxin Ling, Jiaxin Sun, et al.
Journal of Ethnopharmacology (2025) Vol. 343, pp. 119446-119446
Closed Access | Times Cited: 1
The Skin–Brain Axis: From UV and Pigmentation to Behaviour Modulation
Anna A. Ascsillán, Lajos V. Kemény
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6199-6199
Open Access | Times Cited: 6
Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson’s Disease
Shayesteh Kokabi Hamidpour, Mobina Amiri, Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson’s Disease
Ling Yi, Eng King Tan, Zhidong Zhou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4643-4643
Open Access | Times Cited: 5
In silico analysis of hub genes and regulatory networks implicates the putamen in non-motor Parkinson’s disease disorders
Stephen Tunmise Akanbi, Joshua Ayodele Yusuf, Thompson Oluwaferanmi Ayandele, et al.
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Influence of Functional Variations in Genes of Neurotrophins and Neurotransmitter Systems on the Development of Retinopathy of Prematurity
Mariza Fevereiro‐Martins, Ana Carolina Santos, Carlos Marques‐Neves, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 898-898
Open Access
Mitochondria-targeted nanovesicles for ursodeoxycholic acid delivery to combat neurodegeneration by ameliorating mitochondrial dysfunction
Shizheng Zhang, Mengmeng Li, Yuan Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
The homozygous LRRK2.p.N1437D point mutation mouse is a novel model of parkinsonism
Linhua Gan, Yi‐Min Sun, Xinyue Zhou, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
The potential of brain organoids in addressing the heterogeneity of synucleinopathies
Xiaojun Diao, Claudio Soto, Fei Wang, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Role of HCN channels in the functions of basal ganglia and Parkinson’s disease
Zengxin Qi, Yan Qi, Xiu‐Juan Fan, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Tricin promoted ATG-7 dependent autophagic degradation of α-synuclein and dopamine release for improving cognitive and motor deficits in Parkinson's disease
Xingxia Wang, Wei Hu, Liqun Qu, et al.
Pharmacological Research (2023) Vol. 196, pp. 106874-106874
Open Access | Times Cited: 9
Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson’s disease mouse model through activating GHS-R1a/D2R heterodimers
Tingting Tang, Mingxia Bi, Mei-ning Diao, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 8, pp. 1564-1575
Open Access | Times Cited: 8
Golexanolone reduces glial activation in the striatum and improves non-motor and some motor alterations in a rat model of Parkinson's disease
Paula Izquierdo‐Altarejos, Yaiza M. Arenas, Mar Martinez‐García, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Copper-mediated neurotoxicity and genetic vulnerability in the background of neurodegenerative diseases in C. elegans
Ann-Kathrin Weishaupt, Lysann Ruecker, Torben Meiners, et al.
Toxicological Sciences (2024) Vol. 201, Iss. 2, pp. 254-262
Closed Access | Times Cited: 2
Au@Ag nanoparticles: an analytical tool to study the effect of tyrosine on dopamine levels
Angel Minj, Sushama Sahu, Lavkesh Kumar Singh Tanwar, et al.
RSC Advances (2024) Vol. 14, Iss. 27, pp. 19271-19283
Open Access | Times Cited: 1
Sika Deer Velvet Antler Peptide Exerts Neuroprotective Effect in a Parkinson’s Disease Model via Regulating Oxidative Damage and Gut Microbiota
Ying Liu, Hongyuan Li, Min Yang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 972-972
Open Access | Times Cited: 1
Metabolic Disturbances in a Mouse Model of MPTP/Probenecid-Induced Parkinson’s Disease: Evaluation Using Liquid Chromatography-Mass Spectrometry
Yueyuan Wang, Bo Lv, Kai Fan, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 1629-1639
Open Access | Times Cited: 1
Rotenone exposure causes features of Parkinson`s disease pathology linked with muscle atrophy in developing zebrafish embryo
Thilini Ranasinghe, Yongbo Seo, Hae‐Chul Park, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 136215-136215
Open Access | Times Cited: 1
Shisandra Decoction Alleviates Parkinson’s Disease Symptoms in a Mouse Model Through PI3K/AKT/mTOR Signalling Pathway
Yawen Pan, Mojinzi Chen, Lulu Pan, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2011-2027
Open Access | Times Cited: 1
Saponin‐Encapsulated Microbubbles Protect Dopaminergic Neurons from MPTP‐Induced Oxidative Stress Injury
Zhuxia Zhang, Bingxuan Xu, Tao Lv, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 10
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top